Therefore, the evidence suggests that persistence of ANKRD26 expression in ANKRD26-RT leads to persistent ERK activation, which may in turn be responsible for, or contribute to, reduced megakaryocyte ploidy, impaired proplatelet formation, and subsequent thrombocytopenia. The gene discussed is ANKRD26; the disease is Thrombocytopenia.